Fecal microbiota transplant from long-lived Ames dwarf mice to normal mice reprogrammed the gut microbiome, downregulating senescence markers (p21) and improving metabolic health, which suggests microbiome transplantation could mitigate senescence-associated cancer progression [407]. This evidence concerns the gene CDKN1A and cancer.